Maureen’s Healing Journey in Pictures: A Case Study in Managing a Complex Skin Tear

Provided by Lenora Fitzgerald, RANP Tissue Viability Service, RNP, MSc (Hons), Waterford Older Person Services, Republic of Ireland
Consent to use the details of this case and images was provided by the patient

Introduction to the Case

Patient History:

  • 85-year-old female with fragile skin
  • Known to have atrial fibrillation with pacemaker in situ
  • On anticoagulant medication
  • Mechanism of injury: fall at home lead to a skin tear on her knee, plus a sternal fracture.
  • Extensive bruising and haematoma to the knee

Week 1: Initial Wound (15 May 2024)

Figure 1: Initial Wound
(15 May 2024 – On presentation at the Emergency Department)

Maureen’s Voice:

  • “There was a rolled‑up runner [mat]… I tripped over it… my two knees hit that, and my chest hit a chair.”
  • “Older skin is much more fragile… very, very fragile.”

Emotional Context:

  • Shock at severity; fear of looking at the wound.
Figure 2: Wound Closure Strips applied in Emergency Department

Key Points:

  • Partial flap loss was evident
  • Presence of fragile surrounding skin
  • Initial Emergency Department management for the skin tear was the use of wound closure strips
  • Use of wound closure strips contributed to deterioration

Maureen’s Voice:

“I was frightened… if they pulled the plaster off, I could see a big thing of skin coming off.”

Week 2 – Week 3: Maureen remained in hospital

Figure 3a: Week 2
Figure 3b: Week 3.

Key Points:

  • Steri‑strips remained in place (Figure 3a)
  • Bruising and haematoma continued to evolve (Figure 3a)
  • Week 3 Maureen was referred to the Tissue Viability Nurse but there was no mention of a wound.

Maureen’s Voice:

  • “I felt like there should have been more being done with it.”
  • “I’m glad I didn’t look at it… I would have panicked.”

Week 4: First Tissue Viability In-Patient Assessment

Figure 4: First Tissue Viability In-Patient Assessment

Key Points:

  • Wound size 6cm × 5 cm
  • 40% slough / 60% eschar
  • High purulent malodorous exudate
  • Erythema + mild pain → local infection

Week 5: Progress & Reassessment

Key Points:

  • Maureen remains in hospital
  • Wound area reducing
  • Eschar debrided → 80% slough / 20% granulation
  • Moderate purulent exudate
  • Infection improving (no erythema, no pain)

Week 6: Improvement and Discharge Home

Figure 5: Improvement and Discharge Home

Key Points:

  • 65% slough / 20% hypergranulation / 15% epithelialising
  • Exudate reducing
  • Non-painful, infection resolving

Week 7: Visit to out-patient clinic

Figure 6: Visit to
out-patient clinic

Key Points:

  • Wound size reducing overall but ‘pockets’ of depth were noted in the wound bed (up to 0.8cm)
  • Hypergranulation tissue evident

Week 8 – Week 9: Continued Improvement

Figure 7: Continued Improvement

Week 8:

  • 10% Slough / 40% healthy granulation tissue / 50% epithelising tissue
  • Exudate low, no odour
  • Depth almost resolved
  • There was a significant improvement after only one week of single use NPWT

Week 9:

  • Majority of the wound was epithelialising

Week 10 – Week 11: Wound continued to improve

Key Points:

  • No deterioration
  • Consistency of community care maintained

Week 12 – Week 13: Wound continues to improve

Figure 8a: Week 12
Figure 8b: Week 13

Key Points:

  • Different depths & tissue types
  • One deeper wound (0.8 cm) → further debridement

Maureen’s Voice:

  • “It took an awful lot out of me.”
  • “I live in fear… but it doesn’t stop me doing things.”

Week 14: Near Resolution

Figure 9: Near Resolution

Key Points:

  • Wound size <0.6 cm
  • Minimal exudate

Refer to the ISTAP Best Practice Recommendations for prevention strategies

Case Study Learning Points

  • Never use wound closure strips on skin tears
  • Early identification of skin fragility is essential
  • Importance of clear communication and documentation
  • Person-centred care improves outcomes

Strengths That Supported Healing

  • Highly motivated patient + supportive family
  • Excellent adherence to treatment
  • Strong collaboration between the Tissue Viability Nurse and Community Nurse
  • Regular reviews & rapid response to changes

Final Outcome (14 August 2025)

Figure 10: Final Outcome

Key Points:

  • Skin fully intact, but remains fragile
  • Maureen carries out a daily moisturising routine
  • Awareness of risk factors maintained
  • A positive long-term outcome through partnership care

Maureen’s Voice:

  • “I have to be very, very careful… door handles, dogs, little ones’ legs flying.”
  • “Absolutely frightened of my life to move.”
  • “I have never in my life used moisturising cream… now I put on lots.”
  • “If you don’t moisturise… it’s dryer and easier to break.”
  • “I put on lots of cream… moisturising is very important.”
  • “Drink plenty of water.”

Key themes from Maureen’s narrative:

  • Extremely fragile, thin, “tissue-paper” skin
  • Severe emotional impact (shock, panic, fear of bleeding, fear of movement)
  • Describes wound as “horrific… dreadful… unbelievable”
  • Fear regarding wound closure strip removal and inappropriate adhesive use
  • Long-term lifestyle changes to prevent further trauma

Emphasis on moisturising, hydration, risk reduction, environmental modification

Conclusion

Key Points:

  • This case demonstrates value of structured wound management
  • Highlights role of advanced practice & community collaboration
  • Reinforces importance of assessment, reassessment, and adaptability

Skip to content ­